The protease inhibitor gabexate mesylate targets Raf kinase inhibitor protein and reverses epithelial-mesenchymal transition in triple-negative breast cancer cells. - Deserti M; Sabbioni S; Poli F; Vasuri F; Relli V; Palloni A; Deiana C; Brandi G; Tavolari S (Frontiers in oncology, 2026)